Aragen Life Sciences launches high-potency manufacturing in Hyderabad
The story in brief
Aragen Life Sciences has begun operations at Aragen OneHP, a 15,000 sq ft facility in Hyderabad supporting potent compounds like cytotoxic molecules. The site will enhance Hyderabad's pharmaceutical capabilities by offering integrated discovery to cGMP manufacturing. Aragen's IPO filing marks the next step in scaling its advanced therapeutic development.